Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Psychosom Med. 2020 Jun;82(5):454–460. doi: 10.1097/PSY.0000000000000811

Table 3.

Regression models of the relationship between baseline frontostriatal cerebral blood flow and cardiometabolic risk without systolic blood pressure at follow-up

Model 1 Model 2 Model 3
Baseline Frontostriatal CBF 0.19 ** 0.18 ** 0.16 *
[0.07, 0.31] [0.06, 0.31] [0.03, 0.28]
Baseline Cardiometabolic Risk w/o Blood Pressure 0.73 *** 0.73 *** 0.72 ***
[0.61, 0.85] [0.60, 0.85] [0.59, 0.85]
Baseline Total CBF −0.07 −0.03
[−0.20, 0.05] [−0.16, 0.10]
Age 0.04
[−0.09, 0.17]
Sex −0.25
[−0.53, 0.02]
Race −0.06
[−0.34, 0.22]
Education 0.04
[−0.10, 0.19]
N 109 109 109
R2 0.59 0.60 0.62

Standardized regression coefficients are reported with the 95% confidence interval below in brackets. Each model is adjusted for cardiometabolic risk at baseline. Model 1 is unadjusted for any further covariates. Model 2 is adjusted for total cerebral blood flow at baseline. Model 3 is also adjusted for age, sex, race, and education. CBF = Cerebral blood flow;

***

p < 0.001;

**

p < 0.01;

*

p < 0.05.